Patents by Inventor Charles M. Blaha

Charles M. Blaha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140287134
    Abstract: The teachings are directed to a medical device having a drug-retaining coating that at least substantially delays the initial elution of a drug for a time effective at forming a functional endothelium over a surface of the medical device.
    Type: Application
    Filed: January 10, 2014
    Publication date: September 25, 2014
    Applicant: PLS Technologies, LLC
    Inventors: John Thao To, Charles M. Blaha
  • Patent number: 8628790
    Abstract: The teachings are directed to a medical device having a drug-retaining coating that at least substantially delays the initial elution of a drug for a time effective at forming a functional endothelium over a surface of the medical device.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: January 14, 2014
    Assignee: PLS Technologies, LLC
    Inventors: John Thao To, Charles M. Blaha
  • Publication number: 20110086081
    Abstract: The teachings are directed to a medical device having a drug-retaining coating that at least substantially delays the initial elution of a drug for a time effective at forming a functional endothelium over a surface of the medical device.
    Type: Application
    Filed: October 8, 2010
    Publication date: April 14, 2011
    Applicant: Specialized Vascular Technologies, Inc.
    Inventors: John Thao To, Charles M. Blaha
  • Publication number: 20100119578
    Abstract: A unique method and coatings are provided to promote/allow early stage tissue encapsulation/endothelization of medical devices while effectively controlling excessive tissue buildup by eluting antiproliferative therapeutic agent within a body of a patient. The method involves using a therapeutic agent that suppresses excessive extracellular matrix proliferation and allows/promotes thin tissue healing/encapsulation/endothelization of the device. Optimized timing of onset of elution to match onset of excessive extracellular matrix proliferation for maximum effectiveness is achieved by delay barrier with biochemical switch.
    Type: Application
    Filed: November 5, 2009
    Publication date: May 13, 2010
    Applicant: SPECIALIZED VASCULAR TECHNOLOGIES, INC.
    Inventors: John Thao To, Charles M. Blaha, Loc Xuan Phan